ArticleACS omega2026
Research on the Improvement of Oxidative Stress Regulation in Periodontal Ligament Stem Cells and the Promotion of Periodontal Bone Tissue Regeneration by GDF5/ROS-Responsive Degradable Hydrogel.
Article in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Periodontitis is a chronic inflammatory disorder characterized by a sustained inflammatory stimulus that creates an oxidative stress microenvironment within periodontal tissues. Under such conditions, elevated levels of reactive oxygen species (ROS) disrupt the structural and functional integrity of periodontal ligament stem cells (PDLSCs), inhibit osteogenic differentiation, and impair the regeneration of periodontal bone defects. Herein, a ROS-responsive degradable hydrogel loaded with growth differentiation factor 5 (GDF5) was developed to target this pathological microenvironment. By incorporating a thioketal (TK) linker that can be cleaved by ROS, the hydrogel reacts with high concentrations of ROS, improving the oxidative stress environment. As the reaction occurs, the hydrogel is degraded, and during this process, GDF5 is successfully released into the microenvironment, then exerts a sustained osteogenic-promoting effect. This study does not simply expose GDF5 to a harmful environment. Instead, our hydrogel first rapidly scavenges high levels of ROS upon sensing them, creating a redox-balanced microenvironment for the cells; subsequently, it releases GDF5 through an ROS-triggered mechanism. This sequential logic of "clearing the environment first, then treating" is designed to ensure that the released GDF5 can function in an optimized and functional microenvironment, thereby maximizing its protective effects and promoting its osteogenic activity.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.